Indonesian Ministry of Tourism and Creative Economy
-
DATABASE (3519)
-
ARTICLES (812)
In January 2006, Chen Hua (Tony Chen) co-founded Kuxun.cn, a Chinese travel and hotel search engine that was acquired by TripAdvisor in 2009. Chen exited Kuxun in late 2008 and joined Alibaba in early 2009, working on the application of search engine technology. He resigned in February 2011 and started a mobile tech enterprise. In May 2012, he released Changba, an app offering users a portable solo KTV booth that attracted over 1m users in just one week after its release.
In January 2006, Chen Hua (Tony Chen) co-founded Kuxun.cn, a Chinese travel and hotel search engine that was acquired by TripAdvisor in 2009. Chen exited Kuxun in late 2008 and joined Alibaba in early 2009, working on the application of search engine technology. He resigned in February 2011 and started a mobile tech enterprise. In May 2012, he released Changba, an app offering users a portable solo KTV booth that attracted over 1m users in just one week after its release.
Italy's first impact investment fund is focused mainly on assisting Italian startups. Its investment size ranges from €200,000 to €6m. Oltre Venture was founded in 2006 as Oltre Venture I by Luciano Balbo and Lorenzo Allevi, both pioneers in Europe's impact investing ecosystem and each with extensive experience in investment banking, corporate finance and VC firms.In 2016, the company launched a second investment vehicle (Oltre Venture II) which currently has a portfolio of more than 22 startups.
Italy's first impact investment fund is focused mainly on assisting Italian startups. Its investment size ranges from €200,000 to €6m. Oltre Venture was founded in 2006 as Oltre Venture I by Luciano Balbo and Lorenzo Allevi, both pioneers in Europe's impact investing ecosystem and each with extensive experience in investment banking, corporate finance and VC firms.In 2016, the company launched a second investment vehicle (Oltre Venture II) which currently has a portfolio of more than 22 startups.
Hong Kong-based Unicorn Capital Partners was founded in 2015 by Tommy Yip, former partner of Emerald Hill Capital Partners.Unicorn is a leading FoF platform that focuses on venture capital fund and direct investment opportunities in China and Asia. It mainly invests in technology, media, telecommunications and healthcare. By December 2019, Unicorn had $800m in assets under management. It also raised over $350m for its fourth fund.
Hong Kong-based Unicorn Capital Partners was founded in 2015 by Tommy Yip, former partner of Emerald Hill Capital Partners.Unicorn is a leading FoF platform that focuses on venture capital fund and direct investment opportunities in China and Asia. It mainly invests in technology, media, telecommunications and healthcare. By December 2019, Unicorn had $800m in assets under management. It also raised over $350m for its fourth fund.
CSO and co-founder of iLoF
Paula Sampaio is a biochemist who completed a PhD in biomedical sciences at the University of Porto in 1998. She worked as a postdoctoral research fellow at the IMBC INEB Associate Laboratory for four years. In 2002, she was promoted to the role of head of advanced light microscopy and stayed there until 2015. Sampaio is now the national coordinator for Portuguese bioimage platform PPBI and the head of advanced light microscopy at the Institute of Research and Innovation of the University of Porto (i3S).In November 2019, she joined iLoF as CSO and co-founder. iLoF gets technical support from i3S at the R&D center in Porto. The medtech startup focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.
Paula Sampaio is a biochemist who completed a PhD in biomedical sciences at the University of Porto in 1998. She worked as a postdoctoral research fellow at the IMBC INEB Associate Laboratory for four years. In 2002, she was promoted to the role of head of advanced light microscopy and stayed there until 2015. Sampaio is now the national coordinator for Portuguese bioimage platform PPBI and the head of advanced light microscopy at the Institute of Research and Innovation of the University of Porto (i3S).In November 2019, she joined iLoF as CSO and co-founder. iLoF gets technical support from i3S at the R&D center in Porto. The medtech startup focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.
Established in July 2009, GP Capital was co-funded by Shanghai International Group, Jiangsu Shagang Group, Huatai Securities and Hengdian Group. It specializes in establishing and managing industrial investment funds and private equity funds. GP Capital manages the RMB 20 billion Shanghai Financial Development Investment Fund. The Fund was sponsored by the Shanghai Municipal People’s Government with approval from the State Council and National Development and Reform Commission. Half of GP Capital's investment has gone to financial firms. It also invests in sectors such as consumer products, healthcare, new energy, culture, etc.
Established in July 2009, GP Capital was co-funded by Shanghai International Group, Jiangsu Shagang Group, Huatai Securities and Hengdian Group. It specializes in establishing and managing industrial investment funds and private equity funds. GP Capital manages the RMB 20 billion Shanghai Financial Development Investment Fund. The Fund was sponsored by the Shanghai Municipal People’s Government with approval from the State Council and National Development and Reform Commission. Half of GP Capital's investment has gone to financial firms. It also invests in sectors such as consumer products, healthcare, new energy, culture, etc.
Apostolos Apostolakis is a serial entrepreneur turned investor. He has a Civil Engineering degree from NTUA and an MBA from Columbia Business School. His entrepreneurial career started after working two years as a consultant for the Boston Consulting Group until 2004. He became a co-founder and board member of various companies including VentureFriends, InstaShop, Douleutaras.gr, e-food.gr, Doctoranytime.gr and Blueground (formerly Openfund and Taxibeat). In 2010, he started investing in other startups, focusing on e-marketplaces and SaaS.
Apostolos Apostolakis is a serial entrepreneur turned investor. He has a Civil Engineering degree from NTUA and an MBA from Columbia Business School. His entrepreneurial career started after working two years as a consultant for the Boston Consulting Group until 2004. He became a co-founder and board member of various companies including VentureFriends, InstaShop, Douleutaras.gr, e-food.gr, Doctoranytime.gr and Blueground (formerly Openfund and Taxibeat). In 2010, he started investing in other startups, focusing on e-marketplaces and SaaS.
Formerly known as Tribeca Angels, the New York-based Tribeca Early Stage Partners was established in 2014 by John McEvoy. The firm's network of 50 entrepreneurs and business leaders specialize in institutional finance and enterprise technology. Tribeca focuses on early-stage investments in fintechs and ERPs, especially those based in the New York area. Initial investment per startup ranges from US$500,000 to US$1 million. It has invested in 15 startups and managed two exits, Cola and James.
Formerly known as Tribeca Angels, the New York-based Tribeca Early Stage Partners was established in 2014 by John McEvoy. The firm's network of 50 entrepreneurs and business leaders specialize in institutional finance and enterprise technology. Tribeca focuses on early-stage investments in fintechs and ERPs, especially those based in the New York area. Initial investment per startup ranges from US$500,000 to US$1 million. It has invested in 15 startups and managed two exits, Cola and James.
Russia-China Investment Fund (RCIF) is a private equity fund that invests in projects created to advance economic cooperation between Russia and China. RCIF was founded in 2012 by two government-backed funds: Russian Direct Investment Fund (RDIF) and China Investment Corporation (CIC). RCIF has received US$1 billion commitments from both RDIF and CIC. International institutional investors are expected to commit an additional US$2 billion. RCIF will invest at least 70% of its capital in Russia and CIS countries and around 30% in China.
Russia-China Investment Fund (RCIF) is a private equity fund that invests in projects created to advance economic cooperation between Russia and China. RCIF was founded in 2012 by two government-backed funds: Russian Direct Investment Fund (RDIF) and China Investment Corporation (CIC). RCIF has received US$1 billion commitments from both RDIF and CIC. International institutional investors are expected to commit an additional US$2 billion. RCIF will invest at least 70% of its capital in Russia and CIS countries and around 30% in China.
Co-Founder and CEO of iGrow
University of Indonesia (UI) graduate Andreas Senjaya holds a bachelor’s degree in Computer Science. He won the Most Outstanding Student of Computer Science competition and was the vice-chairman of the university’s Computer Science Student Association. Upon graduation, he became a co-founder and CEO of Badr Interactive, a web and mobile applications development company which developed the iGrow platform. He also founded the Nalacity foundation, a social enterprise and Hijab e-commerce store which aims to empower marginalized women and family members of leprosy patients.
University of Indonesia (UI) graduate Andreas Senjaya holds a bachelor’s degree in Computer Science. He won the Most Outstanding Student of Computer Science competition and was the vice-chairman of the university’s Computer Science Student Association. Upon graduation, he became a co-founder and CEO of Badr Interactive, a web and mobile applications development company which developed the iGrow platform. He also founded the Nalacity foundation, a social enterprise and Hijab e-commerce store which aims to empower marginalized women and family members of leprosy patients.
Nickleby Capital is a London-based VC firm that focuses on three main areas: (1) investment capital for companies in the scale-up phase, Series A, Series B, and buyouts, (2) advisory services leveraging proprietary tech, researches and industry network, to accelerate PLCs and private companies' growth, and (3) real estate, advising on commercial and residential properties globally. The firm’s investors are mostly family offices and serial entrepreneurs that have built market-leading companies. The Nickleby Capital’s team is founded by a team of alumni from Goldman Sachs, Rothschild, BDO and Korn Ferry.
Nickleby Capital is a London-based VC firm that focuses on three main areas: (1) investment capital for companies in the scale-up phase, Series A, Series B, and buyouts, (2) advisory services leveraging proprietary tech, researches and industry network, to accelerate PLCs and private companies' growth, and (3) real estate, advising on commercial and residential properties globally. The firm’s investors are mostly family offices and serial entrepreneurs that have built market-leading companies. The Nickleby Capital’s team is founded by a team of alumni from Goldman Sachs, Rothschild, BDO and Korn Ferry.
Chairman of the Board, co-founder, co-inventor of NovoNutrients
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Co-founder of Nongfenqi
Co-founder of Nongfenqi. Zhang received his master’s degree in Electronic and Information Engineering from the Nanjing University of Information Science and Technology. Zhang met Zhou Jian when they both worked at Oufei, and the two collaborated to start Zhou’s computer game company. Zhang himself has invested tens of millions of RMB in Nongfenqi.
Co-founder of Nongfenqi. Zhang received his master’s degree in Electronic and Information Engineering from the Nanjing University of Information Science and Technology. Zhang met Zhou Jian when they both worked at Oufei, and the two collaborated to start Zhou’s computer game company. Zhang himself has invested tens of millions of RMB in Nongfenqi.
Co-founder and CEO of Sego
A graduate of University of Science & Technology of China and Cranfield University (UK), Jiang Xinlian’s work experience spans eight years in overseas sales support and product planning at Huawei and ZTE. He was born in the 1970s.
A graduate of University of Science & Technology of China and Cranfield University (UK), Jiang Xinlian’s work experience spans eight years in overseas sales support and product planning at Huawei and ZTE. He was born in the 1970s.
The Baptist Health group of hospitals is the largest not-for-profit healthcare organization in Arkansas, USA. Founded originally in 1921 as Baptist State Hospital with about 100 beds, Baptist Health is a community-driven healthcare provider. The group comprises the Baptist Health Foundation, a college, a clinical research facility and a healthcare network run by physician partners.
The Baptist Health group of hospitals is the largest not-for-profit healthcare organization in Arkansas, USA. Founded originally in 1921 as Baptist State Hospital with about 100 beds, Baptist Health is a community-driven healthcare provider. The group comprises the Baptist Health Foundation, a college, a clinical research facility and a healthcare network run by physician partners.
PNV Capital is a seed investment fund in Proença-a-Nova, Portugal, co-invested by Busy Angels. The fund is worth about €770,000 and invests an average of about €100,000 per project, with a cap at €200,000.this is all frmo the previous write up as they have no webpage still!
PNV Capital is a seed investment fund in Proença-a-Nova, Portugal, co-invested by Busy Angels. The fund is worth about €770,000 and invests an average of about €100,000 per project, with a cap at €200,000.this is all frmo the previous write up as they have no webpage still!
The edtech startup formerly named Squiline hopes greater fluency in English can boost Indonesia's creative and tourism sectors
Indonesia launches national pitch competition HighPitch 2020 to re-energize its startup ecosystem
With 43 VC investors so far joining as judges and mentors, HighPitch 2020 aims to reconnect investors with young startups across the country amid Covid-19
What Indonesia’s election could mean for startups and investors
Industry players voice their hopes, concerns and expectations as the April presidential election nears
Indonesian startup Traval goes virtual to stay afloat during pandemic
The startup is also trying to set itself apart from mainstream tourism with tours like Zero Waste Journey where travelers do not bring plastic items and even plant trees
HighPitch 2020: Waste management play Octopus, digital concierge service Izy win Makassar battle
Both startups have scored strong traction despite the weight of Covid-19; they are also expanding and keen to explore new opportunities
Beyond billion dollar investment rounds, Indonesia and Singapore are working together to harness the potential of their startup ecosystems
Bekraf: Growing a creative, productive Indonesia
Established to support Indonesia's creative industries as a whole, Bekraf is also an important link between government and the burgeoning startup landscape
HighPitch 2020: Goers wins Indonesia's national startup competition
Event ticketing startup Goers gains new revenue streams with pivot to helping leisure spots go online; hotel SaaS Izy and on-demand medical testing service CekLab also in top three
Gojek CEO resigns to join Indonesia's new cabinet; named education minister
Nadiem Makarim was confirmed as Indonesia's education and culture minister and will become "a passive shareholder" in Gojek
HighPitch 2020: In conversation with top winners and UMG Idealab head Kiwi Aliwarga
Goers, Izy and CekLab demonstrated quick thinking when adapting their businesses to the pandemic, a capability they will need to stay competitive post-Covid
Node: Fighting deforestation with fashionable footwear from agricultural waste
Using patented technology developed with Indonesia’s Ministry of Agriculture, Node turns farm waste and plant materials into biodegradable vegan footwear and shoe components to help fight deforestation.
F&B supplier STOQO collapses, a casualty of Covid-19 restaurant closures in Indonesia
A once promising startup, STOQO's woes reflect the challenges faced by the local F&B industry, which is finding new ways to stay afloat
HighPitch 2020: Yogyakarta chapter won by on-demand lab testing and solar cell startups
Judges lauded the variety of ideas, but said startups could improve their presentations and clearly state the problems they are solving
HighPitch: E-grocery marketplace Pasar20 and healthcare edtech Appskep top the Medan chapter
Representing Sumatra’s startup ecosystem in the national finals later in November, Pasar20 and Appskep have ambitious expansion plans in store
HighPitch 2020: Event ticketing and legal tech startups come up tops in Jakarta chapter
VC judges favored Goers’s strong pivot amid Covid and HAKITA’s outstanding pitch
Sorry, we couldn’t find any matches for “Indonesian Ministry of Tourism and Creative Economy”.
POPULAR DATABASE
